SCHEMBL25520261

SCHEMBL25520261

CC(C)(C)C1CCCC(F)(F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23765253 0.86 ALDH1A1 (0.33)
SCHEMBL11932071 0.86 ALDH1A1 (0.33)
SCHEMBL25474620 0.86 EPHX1 (0.31)
SCHEMBL23765298 0.86 ALDH1A1 (0.33)
SCHEMBL26151498 0.82 ALDH1A1 (0.32)
SCHEMBL26151551 0.80 ALDH1A1 (0.30)
SCHEMBL26153213 0.77
SCHEMBL1091004 0.75 APLNR (0.33)
SCHEMBL23338007 0.73 ALDH1A1 (0.31)
SCHEMBL28567554 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159466-A1 INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. 2023-05-25 US disclosed
US-20230159466-A1 INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. 2023-05-25 US disclosed
US-20230150972-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2023-05-18 US disclosed
US-20230150972-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2023-05-18 US disclosed